Demystifying Regulatory Designations in Drug Development
In this episode, Dr Katherine Bowen and Dr Julie Warner delve into the world of regulatory designations, providing clarity on what these designations offer, the products that qualify, and the pros and...
10 Juli 202425min
Exploring Genome Editing Technologies in Drug Development
In this episode, host Dr. Katherine Bowen, is joined by Harriet Edwards, Associate Director in Regulatory Affairs, to explore the fascinating world of genome editing technologies. Together, they delve...
19 Juni 202423min
The Most Essential Tips for Biotechs Seeking Investment
Welcome to a special edition of Conversations in Drug Development, brought to you by the team at Boyds. In this episode, our host Harriet Edwards hands over the mic to two of her colleagues to discus...
3 Juni 202423min
The Use of ATMPs in Oncology Clinical Trials
How can phase I studies with ATMPs address unmet needs in oncology and what are the challenges? In this episode of Conversations in Drug Development, Dr Katherine Bowen is joined by Pharmaceutical Phy...
21 Maj 202419min
How are GMO Regulations Impacting Clinical Development in Europe?
In this episode of Conversations in Drug Development, our host Harriet Edwards, is joined by Director of Regulatory Affairs, Dr Sabine Ruehle, to discuss the challenges of navigating genetically modif...
25 Apr 202424min
US Drug Development: The Latest Regulatory Trends and Initiatives
In this episode of Conversations in Drug Development, host Dr Harriet Edwards is joined by Katy Rudnick and Dr Julie Warner from Boyds to discuss US regulatory trends and initiatives at the FDA. This ...
19 Mars 202422min
The Regulatory Challenges of Rare Disease Drug Development
To celebrate Rare Disease Day, we are back with another Conversation in Drug Development, this time discussing the unique challenges of rare disease drug development. Dr Eric Hardter, Associate Direct...
28 Feb 202429min
The Drug Development Landscape: Trends and Predictions for 2024
We are kickstarting 2024 with a Conversation in Drug Development with CEO and Founder of Boyds, Professor Alan Boyd. In this podcast episode, our host Harriet Edwards, and Professor Alan Boyd discuss ...
22 Jan 202425min
